The slow agonizing skid continues

Discussion in 'Medtronic' started by anonymous, Sep 21, 2017 at 3:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Hey Omar are you :
    1) watching it
    2) causing it
    3) oblivious to it
    4) apathetic to it
    5) or just plain incompetent

    My thought is all of the above, especially since you are getting paid a boatload of money and don't really feel like you are on the hot seat to deliver results.

    It's time to put an end to the cult and get in some competent management.
     

  2. anonymous

    anonymous Guest

    Hes an extreme leftist from bangladesh more fixated on being a social justice warrior above all else, hence the bottom line fixation, constant RIFs with no end in sight, and no plan to deliver anything remotely market leading
     
  3. anonymous

    anonymous Guest

    J&J exits the diabetes pump business - a huge win for Medtronic. Except that Medtronic can’t get their act together enough to capitalize on the opportunity. Omar falls into the barrel of opportunity and comes out sucking his thumb!

    Shareholders lose again.

    Now the hurricane impact in Puerto Rico. Not that Omar is responsible for that, but if he had been in a better position to service their diabetes business in the first place, then maybe the storm impact wouldn’t have had the negative effect that it is having now. Omar digs himself into a deeper hole!

    Shareholders lose again.

    When is enough? Time for Omar and the inept management he has surrounded himself with to go!
     
  4. anonymous

    anonymous Guest

  5. anonymous

    anonymous Guest

    That’s exactly what I’m talking about! Medtronic’s diabetes business can’t even service their own accounts due to sensor issues and the delay in ramp up of their new pump. Now j&j exits their pump business and Medtronic isn’t in a position to capitalize on it because of their service issues. Lost opportunity.

    Then hurricane Maria comes along and is expected to have a significant impact on revenue.

    If Medtronics diabetes division had their “s” together in the first place, then the increase in sales of the new pump and continuing revenue from the sensor disruption (along with the avoidance in cost due to the recall) coupled with the potential uptick in revenue from the j&j exit might have offset some, if not all of the impact from Maria. GET IT NOW!

    All of this happened under Omar’s watch. The buck has to stop somewhere.

    Stock is down from their high of $89 just a few months ago. The slow agonizing skid continues and it’s time for people to wake up and for Omar to go!
     
  6. anonymous

    anonymous Guest

    Its been discussed that Maria wasn't MDTs fault.

    The hell it wasn't! The execs decided to move 65% OPs within PR to save 3% expense cost of manufacturering products ignoring high risks in doing so.

    So now their decision has cost Medtronic a minimal of 250M. The PR savings have evaporated 100x. This is only the tip of the iceburg because their OPs are screwed big time and for years to come. Do they rebuild in PR are diversify Ops in China or India. It will not be in the US because Omars number one goal is to lower the number of US employees within the company.
     
  7. anonymous

    anonymous Guest

    OPs = operations?